Home › Skin Conditions › Texas › Lewisville
Skin Conditions clinical trials in Lewisville, TX
4 studies for Skin Conditions are looking for participants at sites in and around Lewisville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
RecruitingPhase 3
- Stryde Research-Epiphany Dermatology, Southlake · 11 mi away
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
RecruitingPhase 3
- Stryde Research-Epiphany Dermatology, Southlake · 11 mi away
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
RecruitingPhase 3
- Pediatric Dermatology of North Texas, Grapevine · 9 mi away
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Inmagene Site 8, Southlake · 11 mi away
About Skin Conditions
Your skin is your body's largest organ. It covers and protects your body. Learn about skin conditions, including causes, symptoms, and treatment.
More about Skin Conditions on MedlinePlus
Skin Conditions trials in other cities
- Indianapolis, IN6 studies
- Portland, OR5 studies
- Miami, FL5 studies
- Birmingham, AL5 studies
- Los Angeles, CA5 studies
- Phoenix, AZ5 studies
- Washington, DC4 studies
- Charlotte, NC4 studies
- Hollywood, FL4 studies
- Boston, MA4 studies
- New York City, NY4 studies
- Santa Clarita, CA4 studies
Other studies in Lewisville
- Crohn's Disease8 studies
- Ulcerative Colitis8 studies
- Breast Cancer6 studies
- Type 2 Diabetes5 studies
- Inflammatory Bowel Disease4 studies
- Atopic Dermatitis (Eczema)4 studies
- Spinal Muscular Atrophy4 studies
- Digestive Diseases4 studies
- Geographic Atrophy3 studies
- Macular Degeneration3 studies
- COPD3 studies
- Eczema3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.